NCI, FDA Make Progress On Some Issues, Bu Differences Remain On Endpoints
In Brief: Waldmann, Fisher Win Top Miken Prizes Of $250,000 Each, Six Others Get $50,000
DCBD Board Votes down, Then Approves Organ Systems PA
NCAB Action On Diet FIT “Not Cavalier,” Chairman Korn Says
Why Shouldn’t Scientific Issues Be Discussed In Open Meetings? Editorial
Trending Stories
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- What are The CheckPoints movin’ and groovin’ to this summer?
Join the journal club with the best bops: We asked SITC’s 13-piece band of medical musicians for the top papers and songs of the summer - Senate passes stopgap bill that would ban OMB from finalizing rule that would politicize science
- The defining question of the next decade is not how many drug candidates can be generated, but who decides which ones move forward, and why
Drug development must convene a forum for candid, cross-sector discussion









